Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1927 1
1931 1
1954 1
1957 2
1958 1
1982 1
2002 1
2003 1
2004 3
2005 1
2006 4
2007 3
2008 12
2009 27
2010 2
2011 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 18996102

56 results
Results by year
Filters applied: . Clear all
Page 1
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.
Ruaño G, Bernene J, Windemuth A, Bower B, Wencker D, Seip RL, Kocherla M, Holford TR, Petit WA, Hanks S. Ruaño G, et al. Clin Chim Acta. 2009 Feb;400(1-2):48-55. doi: 10.1016/j.cca.2008.10.009. Epub 2008 Oct 26. Clin Chim Acta. 2009. PMID: 18996102
Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY. Grossman LD, et al. Clin Ther. 2009 Jan;31(1):74-88. doi: 10.1016/j.clinthera.2009.01.004. Clin Ther. 2009. PMID: 19243708 Clinical Trial.
Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes.
Dorkhan M, Dencker M, Stagmo M, Groop L. Dorkhan M, et al. Cardiovasc Diabetol. 2009 Mar 20;8:15. doi: 10.1186/1475-2840-8-15. Cardiovasc Diabetol. 2009. PMID: 19298680 Free PMC article. Clinical Trial.
Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
Buckingham RE, Hanna A. Buckingham RE, et al. Diabetes Obes Metab. 2008 Apr;10(4):312-28. doi: 10.1111/j.1463-1326.2006.00700.x. Diabetes Obes Metab. 2008. PMID: 18333890 Review.
Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.
Stockl KM, Le L, Zhang S, Harada AS. Stockl KM, et al. Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):166-74. doi: 10.1002/pds.1700. Pharmacoepidemiol Drug Saf. 2009. PMID: 19109802
Impact of glitazones on metabolic and haemodynamic parameters in patients with type 2 diabetes mellitus.
Chogtu B, Singh NP, Chawla S, Gupta U. Chogtu B, et al. Singapore Med J. 2009 Apr;50(4):395-9. Singapore Med J. 2009. PMID: 19421684 Free article. Clinical Trial.
Relation between human vasopressin 1a gene variance, fat intake, and diabetes.
Enhörning S, Leosdottir M, Wallström P, Gullberg B, Berglund G, Wirfält E, Melander O. Enhörning S, et al. Am J Clin Nutr. 2009 Jan;89(1):400-6. doi: 10.3945/ajcn.2008.26382. Epub 2008 Dec 3. Am J Clin Nutr. 2009. PMID: 19056558
Genetic predisposition and nongenetic risk factors of thiazolidinedione-related edema in patients with type 2 diabetes.
Chang TJ, Liu PH, Liang YC, Chang YC, Jiang YD, Li HY, Lo MT, Chen HS, Chuang LM. Chang TJ, et al. Pharmacogenet Genomics. 2011 Dec;21(12):829-36. doi: 10.1097/FPC.0b013e32834bfff1. Pharmacogenet Genomics. 2011. PMID: 21934636
Thiazolidinediones and the risk of edema: a meta-analysis.
Berlie HD, Kalus JS, Jaber LA. Berlie HD, et al. Diabetes Res Clin Pract. 2007 May;76(2):279-89. doi: 10.1016/j.diabres.2006.09.010. Epub 2006 Oct 18. Diabetes Res Clin Pract. 2007. PMID: 17055103
Clinical and demographic characteristics of patients receiving different oral hypoglycemic agents.
Gomes T, Juurlink DN, Lipscombe LL, Mamdani MM. Gomes T, et al. Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):756-60. doi: 10.1002/pds.1750. Pharmacoepidemiol Drug Saf. 2009. PMID: 19399918
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page